Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
Top Cited Papers
Open Access
- 4 March 2002
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 195 (5), 643-649
- https://doi.org/10.1084/jem.20012028
Abstract
Celiac disease is caused by a selective lack of T cell tolerance for gluten. It is known that the enzyme tissue transglutaminase (tTG) is involved in the generation of T cell stimulatory gluten peptides through deamidation of glutamine, the most abundant amino acid in gluten. Only particular glutamine residues, however, are modified by tTG. Here we provide evidence that the spacing between glutamine and proline, the second most abundant amino acid in gluten, plays an essential role in the specificity of deamidation. On the basis of this, algorithms were designed and used to successfully predict novel T cell stimulatory peptides in gluten. Strikingly, these algorithms identified many similar peptides in the gluten-like hordeins from barley and secalins from rye but not in the avenins from oats. The avenins contain significantly lower percentages of proline residues, which offers a likely explanation for the lack of toxicity of oats. Thus, the unique amino acid composition of gluten and related proteins in barley and rye favors the generation of toxic T cell stimulatory gluten peptides by tTG. This provides a rationale for the observation that celiac disease patients are intolerant to these cereal proteins but not to other common food proteins.Keywords
This publication has 20 references indexed in Scilit:
- In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitopeNature Medicine, 2000
- Lack of cellular and humoral immunological responses to oats in adults with coeliac diseaseGut, 2000
- The Intestinal T Cell Response to α-Gliadin in Adult Celiac Disease Is Focused on a Single Deamidated Glutamine Targeted by Tissue TransglutaminaseThe Journal of Experimental Medicine, 2000
- Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA‐DQ (α1*0501, (β1*02) or the HLA‐DQ (α1*03, (β1*0302) heterodimersTissue Antigens, 1997
- Peptide binding characteristics of the coeliac disease-associated DQ(α1*0501, β1*0201) moleculeImmunogenetics, 1996
- A Comparison of Diets with and without Oats in Adults with Celiac DiseaseNew England Journal of Medicine, 1995
- Error-Tolerant Identification of Peptides in Sequence Databases by Peptide Sequence TagsAnalytical Chemistry, 1994
- Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.The Journal of Experimental Medicine, 1993
- Gluten, major histocompatibility complex, and the small intestineGastroenterology, 1992
- Tryptophangehalt von GetreideproteinenZeitschrift für Lebensmittel-Untersuchung und Forschung, 1983